These are my thoughts:
- From what I've heard the Gen Cards market is actually decent in comparison. Many groups where I live have stocked up on subspecialists and don't have as many gen cards guys doing the leg work in clinic for the referral base.
- I think interventional will continue to do alright as the shift to more hospital based employees continues. They provide STEMI call and still are huge revenue boosters for their hospitals.. Plus I think the real future of cardiology is the structural stuff (unless AF ablation makes a U turn)
- I think EP would make me most nervous. There was thought to be a lack of EP physicians in the early 2000s and w/ the hype of AF ablation, new device guidelines at the time, there was a huge push to increase EP numbers. I think that saturated the market.. These guys are also younger in comparison w/ interventional/general guys, so there's not going to be a wave of old-timers retiring. To me, the future of EP is 90% on AF ablation. But w/ 1st and 2nd time procedure rates still iffy at best and no super solid mortality data AND with the uncertain economic reimbursement questions in the future, AF ablation makes me nervous. I believe there will always be a role, but don't know how big of a role going forward..
So, I actually think Gen Cards guys will do be okay - Their main questions would be is imaging reimbursement cont to drop.. will midlevels ever encroach on their clinic territory in the next decade - will there be more restrictions on who can read echo's, nucs, ect.. basically a required imaging fellowship that would limit Gen Cards guys access -